Vor Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $3,686 |
Gross Profit | -2,100 | -825 | -865 | |
EBITDA | -812,682 | -241,513 | -32,466 | -29,847 |
EBIT | -812,684 | -243,550 | -33,291 | -30,712 |
Net Income | -812,684 | -1,573,669 | -32,486 | -30,712 |
Net Change In Cash | 0 | 0 | 0 | 3,686 |
Free Cash Flow | -53,906 | -35,336 | -31,297 | -24,135 |
Cash | 160,462 | 190,574 | 50,047 | 81,949 |
Basic Shares | 6,681 | 6,263 | 6,241 | 3,435 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,528 | -3,492 | -8,960 | -4,451 |
EBITDA | -117,657 | -114,371 | -83,134 | -67,584 |
EBIT | -121,185 | -117,863 | -92,094 | -69,018 |
Net Income | -116,914 | -117,863 | -92,094 | -68,899 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -62,095 | 72,116 | ||
Free Cash Flow | -99,889 | -101,361 | -93,606 | -73,038 |
Cash | 81,949 | 31,360 | 57,706 | 119,801 |
Basic Shares | 3,435 | 3,359 | 1,977 | 1,858 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$121.63 |
2025-06-30 | -$251.24 |
2025-03-31 | -$0.26 |
2024-12-31 | -$0.44 |
